ArticleHuman vaccines & immunotherapeutics2021
Understanding primary care physician perspectives on recommending HPV vaccination and addressing vaccine hesitancy.
Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Trial
- Impact of school nurse education on factors influencing HPV vaccine communication with parents.Human vaccines & immunotherapeutics · 2026Article
- Family Physicians' Knowledge Levels and Awareness Regarding HPV Infection and HPV Vaccines.Healthcare (Basel, Switzerland) · 2026Article
- Article
- Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children.Human vaccines & immunotherapeutics · 2025Article
- Strategies, Barriers, and Facilitators for Healthcare Professionals to Recommend HPV Vaccination: A Systematic Review.Vaccines · 2025Review
- Benefits, challenges, and strategies related to using presumptive recommendations for HPV vaccination: A qualitative study with rural and non-rural-serving primary care professionals.Human vaccines & immunotherapeutics · 2024Article
- Navigating vaccine hesitancy: Strategies and dynamics in healthcare professional-parent communication.Human vaccines & immunotherapeutics · 2024Article
- Pediatric providers' views on participating in an HPV Vaccine Quality Improvement Intervention: a qualitative analysis.BMC pediatrics · 2024Article
- Article
- HPV Vaccination Information Access, Needs, and Preferences Among Black and Hispanic Mothers.Journal of health communication · 2024Article
- Understanding Clinic and Community Member Experiences with Implementation of Evidence-Based Strategies for HPV Vaccination in Safety-Net Primary Care Settings.Prevention science : the official journal of the Society for Prevention Research · 2024Article
- Recommending HPV vaccination at age 9 to reduce health disparities: Communication challenges and opportunities.Human vaccines & immunotherapeutics · 2023Article
- Article
- Examining the Barriers and Opportunities for Human Papillomavirus Vaccine Delivery in Cancer Care Settings: A Mixed-Methods Study.Cancer prevention research (Philadelphia, Pa.) · 2023Article
- Pediatricians' perspectives on COVID-19 and HPV vaccine hesitancy.Human vaccines & immunotherapeutics · 2023Article
- Overcoming barriers to HPV vaccination in rural Vermont through a multicomponent peer-based approach.Human vaccines & immunotherapeutics · 2022Review
- Healthcare providers' practice protocols, strategies, and needed tools to address parental HPV vaccine hesitancy: An exploratory study.Human vaccines & immunotherapeutics · 2022Article
- Impact of Parental Knowledge and Beliefs on HPV Vaccine Hesitancy in Kenya-Findings and Implications.Vaccines · 2022Article
- Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey.BMC public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
HPV vaccination rates have improved in recent years, but remain suboptimal in the United States. Physician recommendation is associated with increased uptake; however, specific strategies used by physicians to recommend the vaccine and address hesitancy are underexplored. We iteratively conducted qualitative in-depth interviews with family medicine and pediatrics/adolescent medicine physicians recruited from four primary care settings (federally qualified health centers and hospital-affiliated practices) within a large academic-hospital system in New Jersey. Interviews aimed to understand factors influencing physician recommendations. Transcripts were analyzed iteratively using a team-based, thematic content analysis approach. All physicians reported strong support for HPV vaccination, intention to recommend for target age groups, and providing factsheets to parents. Many physicians used electronic medical records and/or the state immunization registry for monitoring vaccinations, but few were able to report their own clinic-level rates. The majority said they needed to overcome both hesitancy for at least 10-30% of parents and misinformation from the internet. Most cited having their own children vaccinated for HPV as a first-line strategy for addressing parental hesitancy. Other strategies included using data or professional authority to address safety concerns, linking HPV to cervical cancer, highlighting only needing two doses if vaccinated younger, and normalizing the vaccine. While our findings indicate physicians are knowledgeable about HPV vaccination and recommend it to parents, strategies to overcome parental hesitancy varied. Physician, clinic, and health-system-based strategies need to be adopted to overcome parental hesitancy for HPV vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.